| scholarly article | Q13442814 |
| P50 | author | Babette S Zemel | Q87885758 |
| Justine Shults | Q88049457 | ||
| Robert N Baldassano | Q89270894 | ||
| Krista J Howard | Q109606467 | ||
| Meena Thayu | Q114398285 | ||
| Jon M Burnham | Q117265530 | ||
| P2093 | author name string | Mary B Leonard | |
| Lee A Denson | |||
| Anne Ryan | |||
| P2860 | cites work | Blockade of growth hormone receptor shedding by a metalloprotease inhibitor | Q28266617 |
| Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity | Q28271735 | ||
| A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's disease | Q30858873 | ||
| The reference child and adolescent models of body composition. A contemporary comparison | Q30882215 | ||
| Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition | Q31126681 | ||
| Body composition of a young, multiethnic, male population | Q32186272 | ||
| Epidemiology and the natural course of inflammatory bowel disease | Q33661994 | ||
| Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children | Q33941702 | ||
| Influence of muscle strength on bone strength during childhood and adolescence | Q34396851 | ||
| Sarcopenia is prevalent in patients with Crohn's disease in clinical remission. | Q34591955 | ||
| Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis. | Q34640072 | ||
| Bone mineral density and nutritional status in children with chronic inflammatory bowel disease | Q35349249 | ||
| Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone | Q35840923 | ||
| Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. | Q35855164 | ||
| The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications | Q36477912 | ||
| Body-composition assessment by dual-energy x-ray absorptiometry in subjects aged 4-26 y. | Q36698383 | ||
| Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease | Q37250448 | ||
| Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease | Q37250460 | ||
| The role of liver-derived insulin-like growth factor-I. | Q37381848 | ||
| The meaning and measurement of lean body mass | Q37752291 | ||
| Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways | Q40710858 | ||
| Development and validation of a pediatric Crohn's disease activity index | Q40749458 | ||
| Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. | Q40807199 | ||
| Gender specific alterations of body composition in patients with inflammatory bowel disease compared with controls | Q41678734 | ||
| The LMS method for constructing normalized growth standards | Q44055571 | ||
| Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein | Q47361728 | ||
| Body composition measured by dual-energy X-ray absorptiometry in patients who have undergone small-intestinal resection | Q47817358 | ||
| Centers for Disease Control and Prevention 2000 Growth Charts for the United States: Improvements to the 1977 National Center for Health Statistics Version | Q57196021 | ||
| Improvement in Biomarkers of Bone Formation During Infliximab Therapy in Pediatric Crohn's Disease: Results of the REACH Study | Q59497145 | ||
| Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms | Q59684106 | ||
| Multifaceted roles of TNF-? in myoblast destruction: A multitude of signal transduction pathways | Q60275504 | ||
| Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor | Q67965278 | ||
| Regional body fat distribution in relation to pubertal stage: a dual-energy X-ray absorptiometry study of New Zealand girls and young women | Q71611046 | ||
| Body composition in patients with inflammatory bowel disease: a population-based study | Q73695108 | ||
| Twenty-four-hour energy balance in Crohn disease patients: metabolic implications of steroid treatment | Q74081598 | ||
| Metabolic features of inflammatory bowel disease in a remission phase of the disease activity | Q74747059 | ||
| Regulation of insulin-like growth factor-I and of insulin-like growth factor binding protein-1, -3 and -4 in cocultures of rat hepatocytes and Kupffer cells by interleukin-6 | Q77110539 | ||
| Energy and substrate metabolism in patients with active Crohn's disease | Q77325694 | ||
| Body composition development of adolescent white females: the Penn State Young Women's Health Study | Q77471055 | ||
| Effect of disease localization on the anthropometric and metabolic features of Crohn's disease | Q77709346 | ||
| Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle: a role for autocrine/paracrine insulin-like growth factor I | Q79421896 | ||
| Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease | Q79502824 | ||
| Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids | Q80975137 | ||
| Body-composition alterations consistent with cachexia in children and young adults with Crohn disease | Q81023767 | ||
| Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase | Q81650464 | ||
| Body composition and muscle strength as predictors of bone mineral density in Crohn's disease | Q83585972 | ||
| Validation of a self-administered instrument to assess stage of adolescent development | Q86912908 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| P304 | page(s) | 430-438 | |
| P577 | publication date | 2010-04-22 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease | |
| P478 | volume | 139 |
| Q34534944 | Association of chronic kidney disease with muscle deficits in children |
| Q34132963 | Body composition analysis in the pediatric population |
| Q30413619 | Body composition and pulmonary function in cystic fibrosis |
| Q39816396 | Body composition estimation using skinfolds in children with and without health conditions affecting growth and body composition. |
| Q35853300 | Bone density and cortical structure after pediatric renal transplantation |
| Q38338277 | CT and MR enterography in Crohn's disease: current and future applications |
| Q33696234 | Changes in bone structure and the muscle-bone unit in children with chronic kidney disease |
| Q30421646 | Changes in inflammation and QoL after a single dose of infliximab during ongoing IBD treatment |
| Q35939987 | Changes in trabecular bone density in incident pediatric Crohn's disease: a comparison of imaging methods |
| Q35962571 | Changes in vitamin D and parathyroid hormone metabolism in incident pediatric Crohn's disease |
| Q36567001 | Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease |
| Q37254246 | Circulating microRNA is a biomarker of pediatric Crohn disease. |
| Q64080518 | Conceptual Model of Lean Body Mass in Pediatric Inflammatory Bowel Disease |
| Q51369930 | Corticosteroids increase protein breakdown and loss in newly diagnosed pediatric Crohn disease. |
| Q30412194 | Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains |
| Q38021282 | Effect of infliximab top-down therapy on weight gain in pediatric Crohns disease. |
| Q38137812 | Endocrine therapy for growth retardation in paediatric inflammatory bowel disease |
| Q36932597 | Fat and lean BMI reference curves in children and adolescents and their utility in identifying excess adiposity compared with BMI and percentage body fat. |
| Q38227083 | Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment |
| Q35695662 | Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases |
| Q36135544 | Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α Antibodies |
| Q34426164 | Growth problems in children with IBD. |
| Q37994130 | How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients? |
| Q34316049 | Impaired bone health in inflammatory bowel disease: a case-control study in 80 pediatric patients |
| Q30300036 | Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's Disease |
| Q50062805 | Increases in IGF-1 after Anti-TNF-α Therapy are Associated with Bone and Muscle Accrual in Pediatric Crohn's Disease |
| Q30277350 | Increases in Sex Hormones during Anti-Tumor Necrosis Factor α Therapy in Adolescents with Crohn's Disease |
| Q47442534 | Inflammatory Bowel Disease: Effects on Bone and Mechanisms |
| Q39147771 | Influence of complex childhood diseases on variation in growth and skeletal development |
| Q34673479 | Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis |
| Q37975414 | Insulin-like growth factor 1: common mediator of multiple enterotrophic hormones and growth factors |
| Q35860718 | Interpretation of body mass index in children with CKD. |
| Q37071224 | Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease |
| Q36906942 | Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation |
| Q35939993 | Muscle torque relative to cross-sectional area and the functional muscle-bone unit in children and adolescents with chronic disease |
| Q40089789 | Musculoskeletal health in newly diagnosed children with Crohn's disease. |
| Q53096952 | Musculoskeletal system in children and adolescents with inflammatory bowel disease: normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fractures. |
| Q53793765 | Nutritional perspectives of children with Crohn's disease: a single-centre cohort observation of disease activity, energy expenditure and dietary intake. |
| Q92527811 | Nutritional status and body composition in children with inflammatory bowel disease: a prospective, controlled, and longitudinal study |
| Q46470367 | Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates |
| Q35065044 | Skeletal health of children and adolescents with inflammatory bowel disease |
| Q38516140 | Systematic review: Body composition in children with inflammatory bowel disease. |
| Q34771160 | Systematic review: body composition in adults with inflammatory bowel disease |
| Q88541175 | The Association of Diet and Exercise With Body Composition in Pediatric Crohn's Disease |
| Q55007762 | The Long-Term Effect of Early Anti-Tumor Necrosis Factor on Restoration of Growth in Pediatric Crohn's Disease. |
| Q54958011 | Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn's disease. |
| Q55386298 | Up-regulation of IGF Binding Protein-3 Inhibits Colonic Inflammatory Response. |
| Q37660677 | Update on nutritional status, body composition and growth in paediatric inflammatory bowel disease |